Evidence map›Paper›PMID 42484477›Full record

ArticleBritish journal of haematology2026

Immunoglobulin replacement after chimeric antigen receptor T-cell therapy in large B-cell lymphoma with hypogammaglobulinaemia: Secondary Center for International Blood and Marrow Transplant Research analysis.

Sarah Makhani, Thilan Tudor, Efrat Luttwak, Mohammad Alhomoud, Maher Abdul-Hay, Jingmei Hsu, Oscar Lahoud, John Leonard, Peter Martin, Samuel Yamshon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah MakhaniDivision of Hematology/Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA.ORCID https://orcid.org/0000-0002-0624-4722
Thilan TudorDivision of Hematology/Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA.
Efrat LuttwakLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0003-0212-2135
Mohammad AlhomoudAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Maher Abdul-HayDivision of Hematology/Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA.
Jingmei HsuDivision of Hematology/Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA.
Oscar LahoudDivision of Hematology/Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA.
John LeonardDivision of Hematology/Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA.
Peter MartinDivision of Hematology/Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA.
Samuel YamshonDivision of Hematology/Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CAR‐T‐cell therapyimmunoglobulin replacement therapylarge B‐cell lymphoma

Identifiers

PMID42484477
PMCPMC13570157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.